Short bowel condition Completed Phase 4 Trials for Ursodeoxycholic acid (DB01586)

Also known as: Short-bowel syndrome / Short Bowel Syndrome / Congenital volvulus

IndicationStatusPhase
DBCOND0020575 (Short bowel condition)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01974336The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome PatientsPrevention